| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
118,790,000 |
| Market
Cap: |
42.71(M) |
| Last
Volume: |
19,275,386 |
Avg
Vol: |
8,983,226 |
| 52
Week Range: |
$0.3595 - $0.3595 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
6,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$43,042 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-09-01 |
4 |
AS |
$235.85 |
$1,239,867 |
D/D |
(5,000) |
706 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-09-01 |
4 |
OE |
$19.08 |
$95,400 |
D/D |
5,000 |
5,706 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-08-31 |
4 |
AS |
$234.64 |
$332,463 |
D/D |
(1,386) |
4,061 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-08-26 |
4 |
D |
$230.34 |
$298,521 |
D/D |
(1,296) |
5,447 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-08-26 |
4 |
D |
$230.34 |
$16,584 |
D/D |
(72) |
6,743 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-08-26 |
4 |
OE |
$5.95 |
$41,180 |
D/D |
6,921 |
6,815 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-08-26 |
4 |
AS |
$227.74 |
$974,740 |
D/D |
(4,167) |
4,061 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-08-24 |
4 |
D |
$233.01 |
$162,408 |
I/I |
(697) |
1,303 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-08-24 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,000 |
2,000 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-08-16 |
4 |
AS |
$223.26 |
$435,750 |
D/D |
(1,866) |
4,061 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-08-16 |
4 |
OE |
$27.60 |
$75,826 |
D/D |
1,866 |
5,927 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-07-26 |
4 |
AS |
$193.09 |
$572,648 |
D/D |
(2,896) |
706 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-07-26 |
4 |
OE |
$5.95 |
$42,960 |
D/D |
2,896 |
3,602 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-07-20 |
4 |
AS |
$200.61 |
$518,982 |
D/D |
(2,409) |
2,811 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-07-15 |
4 |
D |
$179.14 |
$403,602 |
D/D |
(2,253) |
5,220 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-07-15 |
4 |
D |
$179.14 |
$28,842 |
D/D |
(161) |
7,473 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-07-15 |
4 |
OE |
$5.95 |
$137,006 |
D/D |
10,477 |
7,634 |
|
- |
|
| Glenn Gregory M |
President, R&D |
• – – |
2021-07-15 |
4 |
AS |
$177.62 |
$1,014,597 |
D/D |
(5,654) |
2,811 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2021-07-02 |
4 |
AS |
$210.23 |
$11,347,066 |
D/D |
(52,559) |
20,495 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2021-07-02 |
4 |
OE |
$36.60 |
$4,239,511 |
D/D |
52,559 |
73,054 |
|
- |
|
| Young James F |
Director |
– • – |
2021-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
75,090 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2021-07-01 |
4 |
AS |
$209.20 |
$11,201,513 |
D/D |
(52,620) |
20,495 |
|
- |
|
| Erck Stanley C |
President and CEO |
• • – |
2021-07-01 |
4 |
OE |
$25.60 |
$3,240,965 |
D/D |
52,620 |
73,115 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-06-30 |
4 |
AS |
$208.75 |
$615,848 |
D/D |
(2,896) |
706 |
|
- |
|
| Herrmann John A Iii |
EVP, Chief Legal Officer |
• – – |
2021-06-30 |
4 |
OE |
$5.95 |
$42,938 |
D/D |
2,896 |
3,602 |
|
- |
|
602 Records found
|
|
Page 8 of 25 |
|
|
